chr2-174753524-A-C
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PP3_StrongPP5_Moderate
The NM_000079.4(CHRNA1):āc.757T>Gā(p.Phe253Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,868 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ).
Frequency
Consequence
NM_000079.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CHRNA1 | NM_000079.4 | c.757T>G | p.Phe253Val | missense_variant | 6/9 | ENST00000348749.9 | |
CHRNA1 | NM_001039523.3 | c.832T>G | p.Phe278Val | missense_variant | 7/10 | ||
CHRNA1 | XM_017003256.2 | c.853T>G | p.Phe285Val | missense_variant | 6/9 | ||
CHRNA1 | XM_017003257.2 | c.778T>G | p.Phe260Val | missense_variant | 5/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CHRNA1 | ENST00000348749.9 | c.757T>G | p.Phe253Val | missense_variant | 6/9 | 1 | NM_000079.4 | P1 | |
ENST00000442996.1 | n.322-19225A>C | intron_variant, non_coding_transcript_variant | 1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251122Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135704
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461868Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727234
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Myasthenic syndrome, congenital, 1B, fast-channel Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 01, 1999 | - - |
Lethal multiple pterygium syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | This sequence change replaces phenylalanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 253 of the CHRNA1 protein (p.Phe253Val). This variant is present in population databases (rs137852805, gnomAD 0.006%). This missense change has been observed in individual(s) with autosomal recessive congenital myasthenic syndrome (PMID: 10195214). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 18383). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CHRNA1 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects CHRNA1 function (PMID: 10195214). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at